Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice
Here we report on the impact of completely unpurified islet transplantation on the portal vein pressure (PVP) and the hepatic biochemistry in the peritransplant period and on follow-up. Type I diabetic patients underwent simultaneous kidney and islet transplantation. Islets were not purified from th...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2004-01-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/000000004772664905 |
id |
doaj-dfe2a304e3db4294a3e73834671109dd |
---|---|
record_format |
Article |
spelling |
doaj-dfe2a304e3db4294a3e73834671109dd2020-11-25T04:00:21ZengSAGE PublishingCell Transplantation0963-68971555-38922004-01-011310.3727/000000004772664905Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical PracticeSung Ho Hyon0María Candela Ceballos1Mariana Barbich2Rosana Groppa3Luis Grosembacher4María Mercedes Vieiro5Laura Barcan6Salomon Algranati7Leon Litwak8Pablo F. Argibay M.D., Ph.D.9Kidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaHere we report on the impact of completely unpurified islet transplantation on the portal vein pressure (PVP) and the hepatic biochemistry in the peritransplant period and on follow-up. Type I diabetic patients underwent simultaneous kidney and islet transplantation. Islets were not purified from the acinar tissue to prevent loss of endocrine mass. Each patient received a mean 521,846 ± 201,539.4 islet equivalents (7812.1 islet equivalents/kg/recipient). Immunosuppression and peritransplant medication were given according to the Giessen protocol. The islets were injected into the left hepatic lobe through the umbilical vein. PVP was recorded at time 0 and every 5 min throughout cell infusion. Liver function was assessed daily for the first 10 days, and on follow-up. Basal, peak, and final PVP were 12 ± 3.8, 25.1 ± 7.9, and 19.5 ± 6.2 mmHg, respectively (basal vs. final, p < 0.05). Bilirubin, alkaline phosphatase, prothrombin time, and APTT stayed within normal range. Peak aspartate aminotransferase (AST), alanine aminotransferase (ALT), and serum amylase were 109.4 ± 61.2 IU/L (basal vs. peak, not significant), 79.5 ± 56.9 IU/L (basal vs. peak, not significant), and 887.5 ± 153.6 IU/L (basal vs. peak, p = 0.02), respectively. In all cases AST, ALT, and amylase normalized within 6 days posttransplant and remained so on follow-up (longest control, 33 months posttransplant). Although the intrahepatic infusion of unpurified pancreatic islets affects both the portal vein pressure and the hepatic biochemical profile, this effect is transient and does not compromise the safety of the procedure.https://doi.org/10.3727/000000004772664905 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sung Ho Hyon María Candela Ceballos Mariana Barbich Rosana Groppa Luis Grosembacher María Mercedes Vieiro Laura Barcan Salomon Algranati Leon Litwak Pablo F. Argibay M.D., Ph.D. |
spellingShingle |
Sung Ho Hyon María Candela Ceballos Mariana Barbich Rosana Groppa Luis Grosembacher María Mercedes Vieiro Laura Barcan Salomon Algranati Leon Litwak Pablo F. Argibay M.D., Ph.D. Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice Cell Transplantation |
author_facet |
Sung Ho Hyon María Candela Ceballos Mariana Barbich Rosana Groppa Luis Grosembacher María Mercedes Vieiro Laura Barcan Salomon Algranati Leon Litwak Pablo F. Argibay M.D., Ph.D. |
author_sort |
Sung Ho Hyon |
title |
Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice |
title_short |
Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice |
title_full |
Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice |
title_fullStr |
Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice |
title_full_unstemmed |
Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice |
title_sort |
effect of the embolization of completely unpurified islets on portal vein pressure and hepatic biochemistry in clinical practice |
publisher |
SAGE Publishing |
series |
Cell Transplantation |
issn |
0963-6897 1555-3892 |
publishDate |
2004-01-01 |
description |
Here we report on the impact of completely unpurified islet transplantation on the portal vein pressure (PVP) and the hepatic biochemistry in the peritransplant period and on follow-up. Type I diabetic patients underwent simultaneous kidney and islet transplantation. Islets were not purified from the acinar tissue to prevent loss of endocrine mass. Each patient received a mean 521,846 ± 201,539.4 islet equivalents (7812.1 islet equivalents/kg/recipient). Immunosuppression and peritransplant medication were given according to the Giessen protocol. The islets were injected into the left hepatic lobe through the umbilical vein. PVP was recorded at time 0 and every 5 min throughout cell infusion. Liver function was assessed daily for the first 10 days, and on follow-up. Basal, peak, and final PVP were 12 ± 3.8, 25.1 ± 7.9, and 19.5 ± 6.2 mmHg, respectively (basal vs. final, p < 0.05). Bilirubin, alkaline phosphatase, prothrombin time, and APTT stayed within normal range. Peak aspartate aminotransferase (AST), alanine aminotransferase (ALT), and serum amylase were 109.4 ± 61.2 IU/L (basal vs. peak, not significant), 79.5 ± 56.9 IU/L (basal vs. peak, not significant), and 887.5 ± 153.6 IU/L (basal vs. peak, p = 0.02), respectively. In all cases AST, ALT, and amylase normalized within 6 days posttransplant and remained so on follow-up (longest control, 33 months posttransplant). Although the intrahepatic infusion of unpurified pancreatic islets affects both the portal vein pressure and the hepatic biochemical profile, this effect is transient and does not compromise the safety of the procedure. |
url |
https://doi.org/10.3727/000000004772664905 |
work_keys_str_mv |
AT sunghohyon effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT mariacandelaceballos effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT marianabarbich effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT rosanagroppa effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT luisgrosembacher effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT mariamercedesvieiro effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT laurabarcan effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT salomonalgranati effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT leonlitwak effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice AT pablofargibaymdphd effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice |
_version_ |
1724451190214754304 |